Latest high-throughput screening Stories
Blue Sky announced the appointment of Dr. Kelvin Lam as Vice President, Assay Services. Dr.
Numerous potential anti-malarial candidate drugs have been uncovered by investigators from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI), both parts of the National Institutes of Health (NIH).
HAMILTON, N.J., June 22, 2011 /PRNewswire/ -- VENENUM Biodesign, a drug discovery company that utilizes ultra-high throughput screening (UHTS) of its compound collection to identify potential therapeutic agents against its novel disease-based targets, or its partners' targets, announced today that it opened its new medicinal chemistry space at 8 Black Forest Road in Hamilton, NJ.
VINELAND, N.J., May 4, 2011 /PRNewswire/ -- Designed for analytical research and clinical diagnostic testing, Laboratory Supply Distributors Corp. announces the 96-Well Multi-Tier(TM) Micro Plate System.
BellBrook Labs has developed a new HTS assay for screening methyltransferases, the family of enzymes involved in epigenetic modifications that cause cancerous cell growth and metastasis.
UT Southwestern Medical Center capitalizing on Genedata Screener for simultaneous processing of multiple dose-response curve assays in all types of cancer research projects Orlando, FL (PRWEB) March 28, 2011 Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata Screener® 9 for high-throughput screening and high-content screening is used by UT Southwestern Medical Center in Dallas, Texas.
HAMILTON, N.J., March 22, 2011 /PRNewswire/ -- VENENUM Biodesign, a drug discovery company that utilizes ultra-high throughput screening (UHTS) of its compound collection to identify hits against its novel disease-based targets or its partners' targets, announced today that it will be exhibiting at the 17th SBS Annual Conference & Exhibition at the Gaylord Palms Resort and Convention Center in Orlando, Florida, March 27-31, 2011.
BellBrook Labs has developed a miniaturized high content assay for neutrophil chemotaxis in a stable gradient using its proprietary iuvoâ„¢ Microconduit Array platform.
SAN RAMON, Calif., Jan. 5, 2011 /PRNewswire/ -- Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167.
HAMILTON, N.J., Jan.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.